Published in Dig Dis Sci on June 01, 2011
Endoscopic diagnosis of open-type atrophic gastritis is related to the histological diagnosis of intestinal metaplasia and Cdx2 expression. Dig Dis Sci (2011) 1.93
Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther (2010) 1.15
Do we need multiple biopsies for assessing gastric cancer risk? Dig Dis Sci (2011) 1.04
Gastritis: the histology report. Dig Liver Dis (2011) 1.02
Gastric cancer: a well-behaved Helicobacter pylori-related disease? Dig Dis Sci (2011) 0.99
Chronic gastritis as a cancer precursor. Scand J Gastroenterol Suppl (1984) 0.92
Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping. Hum Pathol (2011) 0.82
Helicobacter pylori Infection, Intestinal Metaplasia, and Gastric Cancer Risk in Eastern Siberia. Helicobacter (2011) 0.81
The severity of endoscopic gastric atrophy could help to predict Operative Link on Gastritis Assessment gastritis stage. J Gastroenterol Hepatol (2011) 0.77
Micro-RNA profiling in kidney and bladder cancers. Urol Oncol (2007) 4.35
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol (2009) 3.29
Human gut microbiota community structures in urban and rural populations in Russia. Nat Commun (2013) 2.95
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology (2004) 2.70
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell (2005) 2.66
Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology (2008) 2.63
Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol (2008) 2.32
HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. Cancer Immunol Immunother (2011) 2.16
Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg (2004) 1.88
Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis (2004) 1.66
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine (2004) 1.65
Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol (2008) 1.62
Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori. Clin Gastroenterol Hepatol (2010) 1.58
DNA qualification workflow for next generation sequencing of histopathological samples. PLoS One (2013) 1.57
Barrett's epithelium after antireflux surgery. J Gastrointest Surg (2005) 1.52
Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone. Gastrointest Endosc (2007) 1.51
Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol (2012) 1.51
Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA). Ann Surg (2012) 1.50
Definition of Barrett's esophagus dysplasia: are we speaking the same language? World J Surg (2015) 1.50
Liver steatosis in children with chronic hepatitis C. Am J Gastroenterol (2006) 1.46
Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol (2012) 1.41
Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population. Intern Emerg Med (2010) 1.40
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics (2013) 1.39
An antimetastatic role for decorin in breast cancer. Am J Pathol (2008) 1.34
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J Pathol (2014) 1.33
Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel. PLoS One (2013) 1.32
Staging gastritis: an international proposal. Gastroenterology (2005) 1.29
PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch (2011) 1.28
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers. Oncotarget (2014) 1.28
Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proc Natl Acad Sci U S A (2014) 1.22
MicroRNA expression profiling of male breast cancer. Breast Cancer Res (2009) 1.22
Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake. Clin Endocrinol (Oxf) (2007) 1.20
Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol (2012) 1.18
Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Liver Transpl (2009) 1.18
MicroRNA expression profiling in human Barrett's carcinogenesis. Int J Cancer (2011) 1.17
Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol (2013) 1.15
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups. Oncotarget (2014) 1.14
The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation. J Biol Chem (2013) 1.14
Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? Am J Gastroenterol (2003) 1.12
Neck emergency due to parathyroid adenoma bleeding: a case report. J Med Case Rep (2009) 1.10
Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. Am J Pathol (2009) 1.08
Thyroid-like follicular carcinoma of the kidney: report of two cases with detailed immunohistochemical profile and literature review. Virchows Arch (2012) 1.07
Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC Cancer (2012) 1.07
The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol (2006) 1.07
Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer. Surgery (2010) 1.07
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice. Proc Natl Acad Sci U S A (2013) 1.06
Epithelial-mesenchymal transition in malignant mesothelioma. Mod Pathol (2011) 1.05
Hepatoid adenocarcinoma of the colon: what should we target? Pathol Oncol Res (2011) 1.05
Errors and near misses in digestive endoscopy units. Dig Liver Dis (2012) 1.05
Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol (2011) 1.03
Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. Eur J Cancer Prev (2008) 1.02
Gastritis: the histology report. Dig Liver Dis (2011) 1.02
Programmed cell death 4 protein in esophageal cancer. Oncol Rep (2010) 1.01
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. Hum Pathol (2013) 1.00
The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies. Lab Invest (2012) 0.99
Effects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils. J Infect Dis (2011) 0.99
Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling. Chest (2011) 0.99
Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin Chem (2008) 0.99
Early HER2 dysregulation in gastric and oesophageal carcinogenesis. Histopathology (2012) 0.98
Proepithelin is an autocrine growth factor for bladder cancer. Carcinogenesis (2009) 0.97
The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal secretory cell maturation. J Clin Invest (2013) 0.96
BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. Thyroid (2011) 0.96
Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization. Hepatology (2011) 0.96
MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. Thyroid (2012) 0.96
Autoimmune atrophic gastritis--pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol (2013) 0.96
Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. Eur J Endocrinol (2011) 0.95
Pathology - grading and staging of GEP-NETs. Best Pract Res Clin Gastroenterol (2012) 0.95
Anterior gradient 2 overexpression in lung adenocarcinoma. Appl Immunohistochem Mol Morphol (2012) 0.95
Survivin expression impacts prognostically on NSCLC but not SCLC. Lung Cancer (2012) 0.95
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. Blood (2011) 0.94
Rectal cancer neoadjuvant treatment in elderly patients. Anticancer Res (2006) 0.94
Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients. Clin Cancer Res (2008) 0.94
PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis. Virchows Arch (2012) 0.93
Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: a potential pathway to cancer? Helicobacter (2003) 0.93
Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution. Ann Surg Oncol (2011) 0.93
Hepatic spleen nodules (HSN). Scand J Gastroenterol (2010) 0.92
Pathogenesis of Helicobacter pylori infection. Helicobacter (2012) 0.92
Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism. Int J Cancer (2008) 0.91
Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am J Gastroenterol (2004) 0.91
microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6. Gut (2012) 0.91
Re: CDX2 homeotic gene expression in gastric noninvasive neoplasia. Am J Surg Pathol (2004) 0.91
Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis. World J Gastroenterol (2006) 0.91
Diffuse leptomeningeal glioneuronal tumors: a new entity? Brain Pathol (2009) 0.91
Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis. Carcinogenesis (2008) 0.90
BRAF in primary and recurrent papillary thyroid cancers: the relationship with (131)I and 2-[(18)F]fluoro-2-deoxy-D-glucose uptake ability. Eur J Endocrinol (2010) 0.89
Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters. Scand J Gastroenterol (2007) 0.89
Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig Dis Sci (2006) 0.89